Tag: Syncona
-
Syncona launches Beacon Therapeutics with £96 million financing to develop ophthalmic gene therapies
•
LONDON, UK: London-based healthcare company Syncona Ltd has announced the launch of Beacon Therapeutics Holdings Limited (Beacon Therapeutics),…
-
Syncona invests £15mn in Oxford University spin out, OMass Therapeutics
•
LONDON, UK: Syncona Ltd it has committed £15 million in an oversubscribed £75.5 million Series B financing in…
-
Novartis to buy Syncona’s Gyroscope Therapeutics for $1.5bn
•
LONDON, UK: Syncona Ltd has been reached to sell its portfolio company Gyroscope Therapeutics Holdings to Novartis for…
-
Syncona co-leads Series B financing in Quell Therapeutics of up to $156 million
•
LONDON, UK: Syncona Ltd has committed $25 million (£19 million) to Quell Therapeutics, a world leader in developing…
-
Syncona’s Achilles announces additional financing plans including IPO in USA
•
LONDON: Syncona’s portfolio company, Achilles Therapeutics has announced that it expects to consider additional capital raising options this…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.